Arbutus Biopharma
ABUS
#6383
Rank
HK$7.32 B
Marketcap
HK$37.10
Share price
-1.46%
Change (1 day)
48.61%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): -HK$2.02

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is -HK$2.04. In 2024 the company made an earnings per share (EPS) of -HK$2.98 an increase over its 2023 EPS that were of -HK$3.45.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.02-32.17%
2024-HK$2.98-13.64%
2023-HK$3.45-4.35%
2022-HK$3.61-44.58%
2021-HK$6.51-17%
2020-HK$7.84-65.4%
2019-HK$22.67138.84%
2018-HK$9.49-22.44%
2017-HK$12.23-78.45%
2016-HK$56.78424.64%
2015-HK$10.82-20.19%
2014-HK$13.5687.96%
2013-HK$7.22-142.59%
2012HK$16.94-342.7%
2011-HK$6.98-25.82%
2010-HK$9.4147.8%
2009-HK$6.37-43.55%
2008-HK$11.28158.91%
2007-HK$4.36-111.88%
2006HK$36.67-552.53%
2005-HK$8.10-71.77%
2004-HK$28.71-14.48%
2003-HK$33.57-8.95%
2002-HK$36.8770.07%
2001-HK$21.6848.01%
2000-HK$14.64-38.54%
1999-HK$23.83-24.6%
1998-HK$31.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-HK$0.47-76.92% Bahamas
NRC Health
NRC
HK$5.49-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA